Home >       About the Fund
About the Fund
Intrexon
Synchrony
LevelVision
Pinnacle Pharmaceuticals
Keraderm

Investment Objective

The primary investment objective of NewVa Capital Partners, LP is to achieve long-term capital appreciation by making investments in privately-held companies:

  1. across a broad spectrum of developmental and investment stages, from early-round opportunities to providing expansion capital for existing businesses,

  2. that are operating in, intend to commence operations in, or are willing to relocate all or a significant portion of their business to the NewVa region of southwestern Virginia and

  3. that could potentially benefit from the resources of the Fund's founding limited partners and their respective affiliates and/or the general partner's operational, transactional, banking, financial, research and advisory capabilities.

Investment Criteria

In addition to the guidelines outlined above, the Fund will consider the following criteria when determining whether to invest in a particular company:

  • Focus - The company's investment proposal must represent a unique business opportunity facing execution risk. In assessing the uniqueness of an opportunity, consideration will be given to the distinctiveness within the NewVa region as well as the technology, competitive position or other characteristic that makes the proposed investment attractive.

  • Deal Size - Investments made by the Fund will range from $100,000 (as one portion of a larger investment) to over $1 million. However, the Fund has access to additional resources that may allow a larger investment in conjunction with other parties.